CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
RedHill Biopharma (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is an Israeli pharmaceutical company focused primarily on acquisition and development of late clinical-stage new formulations of existing drugs.
Company (IPO / Went public)
Phone: +972-(0)3-541-3131
21 Ha’arba’a St.
Tel Aviv, 6473921
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Method for treating cancer with combination therapy | Sep 17, 2019 | Mar 16, 2021 | Patent |
| Methods for treating helicobacter pylori infection | Feb 13, 2019 | Jan 26, 2021 | Patent |
| Method for treating crohn's disease using triple antimicrobial all-in-one formulation | Aug 28, 2019 | Sep 08, 2020 | Patent |
| Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms | May 26, 2017 | Jun 02, 2020 | Patent |
| Blister package | Nov 01, 2018 | May 12, 2020 | Patent |
